Fauci then spoke about the updated COVID vaccine, test, and therapeutic guidance just released by the FDA..."And finally, the same holds true for therapeutics, both drugs and biologics, the FDA will provide recommendations on the efficient approaches, how to generate data that potentially could support an EUA for monoclonal antibody products that might actually be effective against emerging variants, which obviously will be an issue because we already know, particularly that the South African variant is in fact obviating the effect of several of the monoclonal antibodies that people have developed (BUT NOT LERONLIMAB - Dr Zaius)